Surfactant effects upon dissolution patterns of carbamazepine immediate release tablet

Archives of Pharmacal Research

Volumn 28, Issue 1, 2005, Pages 120-126

  Lee, Hyeontae ^a   Park, Sang Ae ^b   Sah, Hongkee ^a  

^a Catholic University of Daegu   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

Carbamazepine; Dissolution kinetics; Dissolution test; Sodium lauryl sulfate

Indexed keywords

CARBAMAZEPINE; SURFACTANT;

ARTICLE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; SOLUBILITY; TABLET;

CARBAMAZEPINE; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; SOLUBILITY; SURFACE-ACTIVE AGENTS; TABLETS;

EID: 20344383278     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02975147     Document Type: Article

References (20)

1. Abrahamsson, B., Johansson, D., Torstensson, A., and Wingstrand, K., Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine. Pharm. Res., 11, 1093-1097 (1994).
2. Aunins, J. G., Southard, M., Meyers, R. A., Hemmelstein, K. J., and Stella, V. J., Dissolution of carboxylic acids III. The effect of polyionizable buffers. J. Pharm. Sci., 74, 1305-1316 (1985).
3. Castillo, J. A., Palomo-Canales, J., Garcia, J. J., Lastres, J. L., Bolas, F., and Torrado, J. J., Preparation and characterization of albendazole β-cyclodextrin complexes. Drug Dev. Ind. Pharm., 25, 1241-1248 (1999).
4. Chen, L. R., Wesley, J. A., Bhattachar, S., Ruiz, B., Bahash, K., and Babu, S. R., Dissolution behavior of a poorly water soluble compound in the presence of Tween 80. Pharm. Res., 20, 797-801 (2003).
5. Costa, P. and Lobo, J. M. S., Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev. Ind. Pharm., 27, 811-817 (2001).
6. Crison, J. R., Weiner, N. D., and Amidon, G. L., Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate. J. Pharm. Sci., 86, 384-388 (1997).
7. Dawoodbhai, S. et al., Optimization of tablet formulation talc. Drug Dev. Ind. Pharm., 17, 1343-1371 (1991).
8. FDA, Center for Drug Evaluation and Research. Guidance for Industry - Extended release oral dosage forms: development, evaluation and application of in vitro/in vivo correlation, September 1997b.
9. FDA, Center for Drug Evaluation and Research. Guidance for Industry - Immediate release solid dosage forms: Scale-up and postapproval changes (SUPAC-IR): Chemistry, manufacturing, and controls, in vitro dissolution testing and in vivo bioequivalence test documentation, November, 1995.
10. FDA, Center for Drug Evaluation and Research. Guidance for Industry - SUPAC-MR: Modified release solid oral dosage forms: Scale-up and postapproval changes: Chemistry, manufacturing, and controls; in vitro dissolution testing and in vivo bioequivalence documentation, September 1997a.
11. Jain, A. C. and Adeyeye, M. C., Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether β-cyclodextrins (SBE) and danazol-SBE inclusion complexes. Int. J. Pharm., 212, 177-186 (2001).
12. Kervinen, L. and Yliruusi, J., Modelling S-shaped dissolution curves. Int. J. Pharm., 92, 115-122 (1993).
13. Langernbucher, F., Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmacol., 24, 979-981 (1972).
14. Pena Romero, A. et al., Water uptake and force development in an optimized prolonged release formulation. Int. J. Pharm., 73, 239-248 (1991).
15. Qazi, S., Peter Samuel, N. K., Venkatachalam, T. K., and Uckun, F. M., Evaluating dissolution profiles of an anti-HIV agent using ANOVA and non-linear regression models in JMP software. Int. J. Pharm., 252, 27-39 (2003).
16. Riegelman, S. and Collier, P., The application of statistical moment theory to the evaluation of the in vivo dissolution time and absorption time. J. Pharmacokient. Biopharm., 8, 509-534 (1980).
17. Serajuddin, A. T. and Rosoff, M., pH-solubility profile of papaverine hydrochloride and its relationship to the dissolution rate of sustained-release pellets. J. Pharm. Sci., 73, 1203-1208 (1984).
18. Shah, V. P., Konecny, J. J., Everett, R. L., McCullough, B., Noorizadeh, A. C., and Skelly, J. P., In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm. Res., 6, 612-618 (1989).
19. Sun, W., Larive, C. K., and Southard, M. Z., A mechanistic study of danazol dissolution in ionic surfactant solutions. J. Pharm. Sci., 92, 424-435 (2003).
20. Velasco-De-Paola, M. V. R., Santoro, M. I. R. M., and Gai, M. N., Dissolution kinetics evaluation of controlled-release tablets containing propranolol hydrochloride. Drug Dev. Ind. Pharm., 25, 535-541 (1999).